Follow
Ken Okawa
Ken Okawa
Ragon Institute of MGH, MIT, and Harvard
Verified email at mgh.harvard.edu
Title
Cited by
Cited by
Year
Dual CD4-based CAR T cells with distinct costimulatory domains mitigate HIV pathogenesis in vivo
CR Maldini, DT Claiborne, K Okawa, T Chen, DL Dopkin, X Shan, ...
Nature medicine 26 (11), 1776-1787, 2020
772020
Gp41-targeted antibodies restore infectivity of a fusion-deficient HIV-1 envelope glycoprotein
VR Joshi, RM Newman, ML Pack, KA Power, JB Munro, K Okawa, ...
PLoS Pathogens 16 (5), e1008577, 2020
32020
OP 6.4–00096 High-efficiency CRISPR/Cas9-mediated disruption of ccr5 in human hematopoietic stem progenitor cells generates HIV-refractory immune systems
D Claiborne, Z Detwiler, K Okawa, T Bateson, T Chen, D Scadden, ...
2022
HIV-resistant dual CD28/4-1BB costimulated CAR T cells mitigate HIV pathogenesis in humanized mice.
D Claiborne, C Maldini, K Okawa, T Chen, D Dopkin, X Shan, K Power, ...
Journal of the International AIDS Society 24 (S1), 48-49, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–4